Metronomic Oral Vinorelbine in Patients With Metastatic Tumors
Metronomic Vinorelbine in Patients With Metastatic Tumors: Phase II Translational Study
Sponsor: Hellenic Cooperative Oncology Group
This PHASE2 trial investigates Breast Cancer and Non Small Cell Lung Cancer and is currently completed. Hellenic Cooperative Oncology Group leads this study, which shows 6 recorded versions since 2006 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Jan 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hellenic Cooperative Oncology Group
- University of Ioannina
For direct contact, visit the study record on ClinicalTrials.gov .